Skip to main content
. 2020 Mar 24;10:347. doi: 10.3389/fonc.2020.00347

Figure 2.

Figure 2

After propensity matching, SBRT vs. TACE. (A) overall survival; (B) progression-free survival; (C) local control; (D) intrahepatic control.